Intraprocedural contrast-enhanced ultrasound (CEUS) in liver percutaneous radiofrequency ablation: clinical impact and health technology assessment

@inproceedings{Mauri2014IntraproceduralCU,
  title={Intraprocedural contrast-enhanced ultrasound (CEUS) in liver percutaneous radiofrequency ablation: clinical impact and health technology assessment},
  author={Giovanni Mauri and Emanuele Porazzi and Luca Cova and Umberto Restelli and Tania Tondolo and Marzia Bonfanti and Anna Cerri and Tiziana Ierace and Davide Croce and Luigi Solbiati},
  booktitle={Insights into imaging},
  year={2014}
}
OBJECTIVES To assess the clinical and the economic impacts of intraprocedural use of contrast-enhanced ultrasound (CEUS) in patients undergoing percutaneous radiofrequency ablation for small (<2.5 cm) hepatocellular carcinomas. METHODS One hundred and forty-eight hepatocellular carcinomas in 93 patients were treated by percutaneous radiofrequency ablation and immediate assessment by intraprocedural CEUS. Clinical impact, cost effectiveness, and budget, organisational and equity impacts were… CONTINUE READING